Mutations in the APC gene were more frequent in primary tumors (71.3%), and a significant difference in prevalence was observed comparing the frequency in lymph node metastases and distant organ metastases (60.9% vs 52.2%). This evidence concerns the gene APC and metastatic malignant neoplasm in the lymph nodes.